Patient Support
Read more
Product Info
Read more
Insights
Insights
![Highlights from Orion's webinar:](/globalassets/uk/hcp-professionals/sustweb_mainimage-782x414.jpg)
Highlights from Orion's webinar:
Sustainable care of asthma and COPD partnership between patients and professionals.
Insights
![Insights from Doctor Omar Usmani](/globalassets/uk/hcp-professionals/782x414usmani.jpg)
Insights from Doctor Omar Usmani
The ability of patients with asthma to achieve the correct inspiratory flow rates for different inhalers.
Insights
![Optimal inspiratory flow](/globalassets/uk/hcp-professionals/haughney-lift-image.jpg)
Optimal inspiratory flow
More asthma patients achieve the optimal inspiratory flow rate required for high-resistance inhalers than for low-resistance inhalers.
Insights
![Clinical effectiveness of Fobumix Easyhaler<sup>®</sup> (budesonide/formoterol fumarate dihydrate)](/globalassets/uk/hcp-professionals/easyhaler-and-patients-image.jpg)
Clinical effectiveness of Fobumix Easyhaler® (budesonide/formoterol fumarate dihydrate)
For patients with poorly controlled obstructive airway disease: a real-world study of patient-reported outcomes
Insights
![Switching asthma and COPD patients to Fobumix Easyhaler<sup>®</sup> (budesonide/formoterol fumarate dihydrate)](/globalassets/uk/hcp-professionals/ins_syk_782x414px.jpg)
Switching asthma and COPD patients to Fobumix Easyhaler® (budesonide/formoterol fumarate dihydrate)
Leads to improved clinical outcomes and quality of life in real-world clinical practice
Read more